Bill Text: CT HB06292 | 2015 | General Assembly | Introduced

Connecticut House Bill 6292 (Prior Session Legislation)

Introduced

Bill Title: An Act Concerning The "right To Try" Investigational Treatments And Drugs.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2015-01-22 - Referred to Joint Committee on Public Health [HB06292 Detail]

Download: Connecticut-2015-HB06292-Introduced.html


General Assembly		*Proposed Bill No. 6292*
*January Session, 2015*		LCO No. 1457
		01457
Referred to Committee on PUBLIC HEALTH
Introduced by:
REP. CANDELORA, 86^th Dist. REP. KOKORUDA, 101^st Dist.

AN ACT CONCERNING THE "RIGHT TO TRY" INVESTIGATIONAL TREATMENTS AND DRUGS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That the general statutes be amended to allow (1) terminally ill patients to request access to treatment and drugs that have passed the first clinical trial stage of development but have not received final approval by the federal Food and Drug Administration, and (2) physicians, hospitals and manufacturers of investigational drugs, products and devices to make such treatment, drugs, products and devices available to terminally ill patients without being subject to prosecution.

Statement of Purpose:

To allow terminally ill patients the "right to try" experimental treatments and drugs.